Special Considerations for Advanced Heart Failure Surgeries: Durable Left Ventricular Devices and Heart Transplantation

Armaan F. Akbar; Alice L. Zhou; Annie Wang; Amy S.N. Feng; Alexandra A. Rizaldi; Jessica M. Ruck; Ahmet Kilic

doi:10.3390/jcdd11040119

Special Considerations for Advanced Heart Failure Surgeries: Durable Left Ventricular Devices and Heart Transplantation

Armaan F. Akbar, Alice L. Zhou, Annie Wang, Amy S.N. Feng, Alexandra A. Rizaldi, Jessica M. Ruck, Ahmet Kilic

School of Medicine

Research output: Contribution to journal › Review article › peer-review

Abstract

Heart transplantation and durable left ventricular assist devices (LVADs) represent two definitive therapies for end-stage heart failure in the modern era. Despite technological advances, both treatment modalities continue to experience unique risks that impact surgical and perioperative decision-making. Here, we review special populations and factors that impact risk in LVAD and heart transplant surgery and examine critical decisions in the management of these patients. As both heart transplantation and the use of durable LVADs as destination therapy continue to increase, these considerations will be of increasing relevance in managing advanced heart failure and improving outcomes.

Original language	English (US)
Article number	119
Journal	Journal of Cardiovascular Development and Disease
Volume	11
Issue number	4
DOIs	https://doi.org/10.3390/jcdd11040119
State	Published - Apr 2024

Keywords

heart transplantation
left ventricular assist device
right ventricular failure
risk factors
small left ventricular cavity
temporary mechanical circulatory support
valvular disease

ASJC Scopus subject areas

General Pharmacology, Toxicology and Pharmaceutics
Pharmacology (medical)

Access to Document

10.3390/jcdd11040119

Cite this

@article{da2cfa8244214cb7a1b35e83da849162,

title = "Special Considerations for Advanced Heart Failure Surgeries: Durable Left Ventricular Devices and Heart Transplantation",

abstract = "Heart transplantation and durable left ventricular assist devices (LVADs) represent two definitive therapies for end-stage heart failure in the modern era. Despite technological advances, both treatment modalities continue to experience unique risks that impact surgical and perioperative decision-making. Here, we review special populations and factors that impact risk in LVAD and heart transplant surgery and examine critical decisions in the management of these patients. As both heart transplantation and the use of durable LVADs as destination therapy continue to increase, these considerations will be of increasing relevance in managing advanced heart failure and improving outcomes.",

keywords = "heart transplantation, left ventricular assist device, right ventricular failure, risk factors, small left ventricular cavity, temporary mechanical circulatory support, valvular disease",

author = "Akbar, {Armaan F.} and Zhou, {Alice L.} and Annie Wang and Feng, {Amy S.N.} and Rizaldi, {Alexandra A.} and Ruck, {Jessica M.} and Ahmet Kilic",

note = "Publisher Copyright: {\textcopyright} 2024 by the authors.",

year = "2024",

month = apr,

doi = "10.3390/jcdd11040119",

language = "English (US)",

volume = "11",

journal = "Journal of Cardiovascular Development and Disease",

issn = "2308-3425",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "4",

}

TY - JOUR

T1 - Special Considerations for Advanced Heart Failure Surgeries

T2 - Durable Left Ventricular Devices and Heart Transplantation

AU - Akbar, Armaan F.

AU - Zhou, Alice L.

AU - Wang, Annie

AU - Feng, Amy S.N.

AU - Rizaldi, Alexandra A.

AU - Ruck, Jessica M.

AU - Kilic, Ahmet

PY - 2024/4

Y1 - 2024/4

N2 - Heart transplantation and durable left ventricular assist devices (LVADs) represent two definitive therapies for end-stage heart failure in the modern era. Despite technological advances, both treatment modalities continue to experience unique risks that impact surgical and perioperative decision-making. Here, we review special populations and factors that impact risk in LVAD and heart transplant surgery and examine critical decisions in the management of these patients. As both heart transplantation and the use of durable LVADs as destination therapy continue to increase, these considerations will be of increasing relevance in managing advanced heart failure and improving outcomes.

AB - Heart transplantation and durable left ventricular assist devices (LVADs) represent two definitive therapies for end-stage heart failure in the modern era. Despite technological advances, both treatment modalities continue to experience unique risks that impact surgical and perioperative decision-making. Here, we review special populations and factors that impact risk in LVAD and heart transplant surgery and examine critical decisions in the management of these patients. As both heart transplantation and the use of durable LVADs as destination therapy continue to increase, these considerations will be of increasing relevance in managing advanced heart failure and improving outcomes.

KW - heart transplantation

KW - left ventricular assist device

KW - right ventricular failure

KW - risk factors

KW - small left ventricular cavity

KW - temporary mechanical circulatory support

KW - valvular disease

UR - http://www.scopus.com/inward/record.url?scp=85191761738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85191761738&partnerID=8YFLogxK

U2 - 10.3390/jcdd11040119

DO - 10.3390/jcdd11040119

M3 - Review article

C2 - 38667737

AN - SCOPUS:85191761738

SN - 2308-3425

VL - 11

JO - Journal of Cardiovascular Development and Disease

JF - Journal of Cardiovascular Development and Disease

IS - 4

M1 - 119

ER -

Special Considerations for Advanced Heart Failure Surgeries: Durable Left Ventricular Devices and Heart Transplantation

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this